Misha Mutizwa, M.D.
NPI 1154559375 · Dermatology Physician · Danville, PA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1154559375
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- A126572 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
16 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)28% of score
1,954 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 491 | $62 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 469 | $2 |
| Biopsy of Related Skin Growth, First Growth11102 | 243 | $28 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 228 | $48 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 170 | $93 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 27 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluconazole | 133 | 52 |
| Dupilumabbrand: Dupixent Pen | 119 | 15 |
| Clobetasol Propionate | 97 | 58 |
| Triamcinolone Acetonide | 74 | 49 |
| Apremilastbrand: Otezla | 59 | — |
| Secukinumabbrand: Cosentyx Sensoready (2 Pens) | 56 | — |
| Prednisone | 43 | 19 |
Practice location
Mailing address
Additional practice locations (2)
- 3401 N Broad StPhiladelphia, PA 19140-5103Phone: (215) 707-3376Fax: (215) 707-9510
- 3401 N Broad StPhiladelphia, PA 19140-5103Phone: (215) 707-3376Fax: (215) 707-9510
Registry dates
- Enumerated
- 2009-06-25
- Last updated
- 2020-08-27
- Certified
- 2020-08-27
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.